检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王洪义[1] 吕有勇[1] 崔建涛[1] 何洛文[1] 林本耀[1] 徐光炜[1]
机构地区:[1]北京医科大学临床肿瘤学院北京市肿瘤防治研究所,北京市100036
出 处:《中国肿瘤临床》1999年第10期736-738,共3页Chinese Journal of Clinical Oncology
摘 要:目的: 研究染色体杂合缺失与乳腺癌生物学行为和预后的关系。方法:应用PCR- 限制性长度片段多态性分析(PCR- RFLP) 的方法,对56 例原发性乳腺癌患者3 号染色体短臂3P14 -24 区域杂合缺失(LOH) 进行分析。结果:在染色体3P14 、3P21 、3P24 三个位点上LOH 发生的频率分别为4 .2 % (1/24) 、0(0/9) 和39 .5 % (15/38) ,3P24 位点LOH 发生的频率最高,说明该位点有乳腺癌相关抑制基因存在的可能性。分析3P24 位点的LOH 与临床分期、淋巴结转移和ER、PR 的相关关系,发现在8 例Ⅰ期乳腺癌信息个体中该位点LOH 全部为阴性,在Ⅱ、Ⅲ期病例LOH 阳性率分别为52 .2 % (12/23) 和42 .8 % (3/7) ;在腋淋巴结转移和无转移组病例中分别为66 .7 % (12/18) 、15 % (3/20) ,两组间有显著性差异( P< 0 .01) ;ER 或PR 阴性的乳腺癌也较ER、PR 阳性者有较高的LOH 发生率。说明在Ⅱ、Ⅲ期乳腺癌以及淋巴结阳性、ER 或PR 阴性的肿瘤中该位点的缺失更频繁,提示3P24 位点基因缺失与病程进展快、侵袭性程度高和预后差的肿瘤有关。结论:通?Objective: To study the association of loss of heterozygosity at chromosome 3P with biologic behavior and prognostic significance in human breast cancer. Methods:The loss of heterozygosity (LOH) at chromosome 3P was determined in 56 patients with breast cancer by means of polymerase chain reaction (PCR)-restriction fragment length polymorphisms (RFLP). Results: In 4.2%(1/24), 0%(0/9), 39.5%(15/38) of the tested cases, LOH was determined at 3P14, 3P21,3P24 respectively. Deletion mapping in these tumors indicated that the common region of chromosomal loss resided within band 3P24. These results suggest that one or more putative tumor suppressor genes at this site contributed to the pathogenesis of breast cancer. All the LOH at 3P24 happened in stage Ⅱ(52.2%) or stage Ⅲ(42.8%). In stage Ⅰpatient, no LOH at 3P24 was revealed. The frequency of LOH at the 3P24 locus was higher in breast cancer patients with axillary lymph node metastasis (66.7%) than those in node-negative tumors (15%) (P< 0.01). Most of the LOH at this site were found in node-positive stage Ⅱor stage Ⅲand ER or PR-negative patients. Conclusion: These findings suggest that the measurement of LOH at 3P24 may be an useful predicting marker for lymph node metastasis potential and prognosis of patients with breast cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3